Ginkgo Bioworks Holdings Revenue 2020-2023 | DNA
Ginkgo Bioworks Holdings revenue from 2020 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Ginkgo Bioworks Holdings Annual Revenue
(Millions of US $) |
| 2022 |
$478 |
| 2021 |
$314 |
| 2020 |
$77 |
| 2019 |
$54 |
Ginkgo Bioworks Holdings Quarterly Revenue
(Millions of US $) |
| 2023-03-31 |
$81 |
| 2022-12-31 |
$98 |
| 2022-09-30 |
$66 |
| 2022-06-30 |
$145 |
| 2022-03-31 |
$168 |
| 2021-12-31 |
$148 |
| 2021-09-30 |
$78 |
| 2021-06-30 |
$44 |
| 2021-03-31 |
$44 |
| 2020-12-31 |
|
| 2020-09-30 |
$13 |
| 2019-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$3.170B |
$0.478B |
|
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
|
